(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 3662.70 | 3842.50 | -4.68 | 3662.70 | 3842.50 | -4.68 | 14122.90 | 17357.00 | -18.63 |
| Other Income | 167.20 | 42.50 | 293.41 | 167.20 | 42.50 | 293.41 | 629.00 | 408.30 | 54.05 |
| PBIDT | 373.60 | 299.90 | 24.57 | 373.60 | 299.90 | 24.57 | 1132.60 | 2947.10 | -61.57 |
| Interest | 12.90 | 19.30 | -33.16 | 12.90 | 19.30 | -33.16 | 118.00 | 76.20 | 54.86 |
| PBDT | 360.70 | 280.60 | 28.55 | 360.70 | 280.60 | 28.55 | 3284.40 | 2910.90 | 12.83 |
| Depreciation | 286.90 | 299.30 | -4.14 | 286.90 | 299.30 | -4.14 | 1190.30 | 1084.10 | 9.80 |
| PBT | 73.80 | -18.70 | -494.65 | 73.80 | -18.70 | -494.65 | 2094.10 | 1826.80 | 14.63 |
| TAX | 18.50 | -0.20 | -9350.00 | 18.50 | -0.20 | -9350.00 | 504.70 | 197.20 | 155.93 |
| Deferred Tax | 18.50 | -4.60 | -502.17 | 18.50 | -4.60 | -502.17 | 500.30 | 197.20 | 153.70 |
| PAT | 55.30 | -18.50 | -398.92 | 55.30 | -18.50 | -398.92 | 1589.40 | 1629.60 | -2.47 |
| Equity | 140.80 | 140.80 | 0.00 | 140.80 | 140.80 | 0.00 | 140.80 | 140.80 | 0.00 |
| PBIDTM(%) | 10.20 | 7.80 | 30.69 | 10.20 | 7.80 | 30.69 | 8.02 | 16.98 | -52.77 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1900.90 |
| Dr. Reddys Labs. | 1175.00 |
| Cipla | 1426.20 |
| Lupin | 2193.00 |
| Zydus Lifesciences | 1120.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: